Martins João Pedro, das Neves José, de la Fuente María, Celia Christian, Florindo Helena, Günday-Türeli Nazende, Popat Amirali, Santos José Luis, Sousa Flávia, Schmid Ruth, Wolfram Joy, Sarmento Bruno, Santos Hélder A
Drug Research Program, Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
i3S - Instituto de Investigação e Inovação em Saúde & INEB - Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal.
Drug Deliv Transl Res. 2020 Jun;10(3):726-729. doi: 10.1007/s13346-020-00743-2.
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.
这篇评论文章传达了控释协会纳米医学与纳米级递送焦点小组委员会对于美国国立癌症研究所（NCI）停止对癌症纳米技术卓越中心（CCNEs）资助的决定的看法，以及随后拓宽了这一讨论范围的社论文章。图形摘要。
